1. Home
  2. SATL vs AUTL Comparison

SATL vs AUTL Comparison

Compare SATL & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Satellogic Inc.

SATL

Satellogic Inc.

BUY

Current Price

$3.98

Market Cap

529.2M

Sector

Technology

ML Signal

BUY

Logo Autolus Therapeutics plc

AUTL

Autolus Therapeutics plc

HOLD

Current Price

$1.58

Market Cap

596.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SATL
AUTL
Founded
2010
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
529.2M
596.2M
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
SATL
AUTL
Price
$3.98
$1.58
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
9
Target Price
★ $10.20
$8.73
AVG Volume (30 Days)
★ 4.4M
1.5M
Earning Date
11-09-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 85.94
N/A
EPS
N/A
★ N/A
Revenue
★ $17,707,000.00
$10,120,000.00
Revenue This Year
$166.10
$98.68
Revenue Next Year
$32.37
$28.47
P/E Ratio
★ N/A
N/A
Revenue Growth
37.58
★ 496.00
52 Week Low
$1.26
$1.18
52 Week High
$12.00
$2.58

Technical Indicators

Market Signals
Indicator
SATL
AUTL
Relative Strength Index (RSI) 34.52 33.76
Support Level $3.34 $1.55
Resistance Level $6.18 $1.73
Average True Range (ATR) 0.32 0.09
MACD -0.19 -0.02
Stochastic Oscillator 7.34 7.78

Price Performance

Historical Comparison
SATL
AUTL

About SATL Satellogic Inc.

Satellogic Inc is a vertically integrated Earth observation company that designs, manufactures, and operates satellite systems, delivering decision-grade insights at scale to government and commercial customers. Through an end-to-end production and operations model, it provides governments with flexible options across their journey toward sovereign Earth observation. From access to high-frequency imagery and managed space systems to full satellite ownership, to supporting autonomous data availability and long-term technological independence. It has monitoring and alert-driven workflows that help defense and intelligence agencies, civil governments, and commercial operators transition from reactive tasking to proactive decision-making, providing mission-critical data when needed.

About AUTL Autolus Therapeutics plc

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.

Share on Social Networks: